Warning Letters Special Report: The Decline And Fall Of Morton Grove Pharmaceuticals

It was bad enough that out-of-specification investigations were hugely inadequate, but the firm’s response to the FDA’s findings was even worse.

2022 Warning Letters Special Report
how morton grove wound up with a consent decree • Source: Shutterstock

More from Manufacturing

More from Compliance